Cargando…
Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits
Importance: Enzyme-inducing antiseizure medications (eiASMs) have been hypothesized to be associated with long-term risks of cardiovascular disease. Objective: To quantify and model the putative hazard of cardiovascular disease secondary to eiASM use. Design, Setting, and Participants: This cohort s...
Autor principal: | Vossler, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988723/ https://www.ncbi.nlm.nih.gov/pubmed/35444497 http://dx.doi.org/10.1177/15357597211070392 |
Ejemplares similares
-
Measure for Measure: Measuring the Usefulness of Measuring Antiseizure
Medication Levels
por: Faught, Edward
Publicado: (2020) -
Sometimes, More Is More: Antiseizure Medication polytherapy Is Associated With Decreased SUDEP Risk
por: Lee, Jong Woo
Publicado: (2021) -
Exploring the Cognitive Outcomes of Children Prenatally Exposed to
Antiseizure Medications: Mind the Lab
por: Eyal, Sara
Publicado: (2021) -
Putting a Band-Aid on a Broken Leg: Antiseizure Medications Are Inferior to Immune Therapies in Autoimmune Epilepsy
por: Gaspard, Nicolas
Publicado: (2019) -
Diagnostic Yield and Treatment Changes After Genetic Testing of Adults With
Epilepsy
por: Vossler, David G.
Publicado: (2022)